Pharmacists should be aware of various causes of weight gain in midlife women, as well as pharmacotherapies, supplements, and OTC products that either could lead to weight gain or could assist with weight loss
Este patrn podra repetirse en usuarios de medicamentos GLP-1 utilizados para tratar la diabetes tipo 2 y la obesidad
At the end of the day, the researchers argue, everyone needs proper follow-up and management of their obesity treatment, no matter which option they choose
GLP-1 RAs continue to be a cornerstone of antidiabetic therapy but should not be misconstrued as a panacea
25 , 321335 (2000) Koole, C
"Retatrutide phase 2 obesity trial outcomes and metabolic effects." Clinical Trial Registry Database